We are live on ! Find out more
NYMX

Nymox Pharmaceutical Corp
NYMX

Delisted

NYMX was delisted on the 6th of July, 2023.

Back to rankings

47 hedge funds and large institutions have $6.32M invested in Nymox Pharmaceutical Corp in 2020 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 10 increasing their positions, 9 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 8

22% more capital invested

Capital invested by funds: $5.19M → $6.32M (+$1.14M)

11% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 9

4% more funds holding

Funds holding: 45 → 47 (+2)

12% less call options, than puts

Call options by funds: $99K | Put options by funds: $113K

Holders
47
Holders Change
+2
Holders Change %
+4.44%
% of All Funds
1.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
10
Reduced
9
Closed
8
Calls
$99K
Puts
$113K
Net Calls
-$14K
Net Calls Change
-$1K

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$644K
2
Goldman Sachs
Goldman Sachs
New York
+$336K
3
Renaissance Technologies
Renaissance Technologies
New York
+$194K
4
Millennium Management
Millennium Management
New York
+$125K
5
FCFC
First Citizens Financial Corp
Iowa
+$98.5K

Top Sellers

Rank Fund Capital Flow
1
6CM
683 Capital Management
New York
-$189K
2
Bank of America
Bank of America
North Carolina
-$118K
3
ECM
ExodusPoint Capital Management
New York
-$116K
4
FDCDDQ
Federation des caisses Desjardins du Quebec
Quebec, Canada
-$98.2K
5
Citadel Advisors
Citadel Advisors
Florida
-$80.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
AGM
51
Alpine Global Management
New York
– -$38K -17,196 Closed
TRCT
52
Tower Research Capital (TRC)
New York
– -$25K -11,515 Closed
LNC
53
Lincoln National Corp
Pennsylvania
– -$22K -10,000 Closed
SPIA
54
Steward Partners Investment Advisory
New York
– -$1K -600 Closed
VRM
55
Vectors Research Management
New York
– -$1K -500 Closed
1 2
3

NYMX Hedge Fund Activity: Q1 2020 in Review

47 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Nymox Pharmaceutical Corp (NYMX) for Q1 2020, worth a combined $6.32M — up 22% from $5.19M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new NYMX positions and 8 closed out — a net gain of 4 holders — while 10 added to existing stakes and 9 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $644K. The largest seller was 683 Capital Management, exiting entirely with an estimated $189K sold.

  • 47 institutional investors held Nymox Pharmaceutical Corp (NYMX) as of Q1 2020, up from 45 in Q4 2019.
  • Funds reported $6.32M of Nymox Pharmaceutical Corp stock for Q1 2020, up 22% quarter-over-quarter.
  • 12 funds opened new Nymox Pharmaceutical Corp positions in Q1 2020 and 8 closed out, a net change of +4 holders.
  • The largest Nymox Pharmaceutical Corp buyer in Q1 2020 was Susquehanna International Group, an estimated $644K added.
  • The largest Nymox Pharmaceutical Corp seller in Q1 2020 was 683 Capital Management, an estimated $189K sold.

Based on aggregated 13F filings for Q1 2020.